Yubo International Biotech Limited
YBGJ
$0.0545
-$0.0155-22.14%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -48.55% | -248.89% | -72.99% | -33.19% | 0.82% |
| Total Depreciation and Amortization | -3.58% | 196.30% | 471.08% | 618.35% | 588.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -168.06% | 31.63% | -- |
| Change in Net Operating Assets | -6.46% | 285.88% | 227.26% | -14.40% | -53.85% |
| Cash from Operations | -81.01% | -10.72% | -5.57% | -20.76% | -22.98% |
| Capital Expenditure | -- | -- | -- | -296.88% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 72.11% | -- |
| Cash from Investing | -- | -- | 306.03% | 0.66% | -- |
| Total Debt Issued | 38.47% | 11.43% | 11.43% | 11.43% | 11.43% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 88.71% | 55.93% | 52.14% | 26.08% | 11.43% |
| Foreign Exchange rate Adjustments | -911.89% | -268.27% | -245.60% | -38.99% | 50.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.93% | 103.31% | 108.31% | 35.86% | -26.88% |